Important Update for the PWS Community: HERO Phase 3 Trial for ARD-101 Voluntarily Paused

We would like to share an important update from Aardvark Therapeutics. Aardvark has announced a voluntary pause of the Phase 3 HERO clinical trial, which is evaluating ARD‑101 for the treatment of hyperphagia in people with Prader‑Willi syndrome. The decision to pause the trial is based on reversible cardiac observations identified in a non-PWS, separate healthy...